Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD

Parkinson’s disease (PD) is the second most common neurodegenerative disorder next to Alzheimer’s disease. Most PD cases are considered to be sporadic and despite considerable scientific effort, the underlying cause(s) still remain(s) enigmatic. In particular, it is unknown to which extent epigeneti...

Full description

Bibliographic Details
Main Authors: Laura de Boni, Ullrich Wüllner
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00276/full
id doaj-54c2494225fb490fbda6e1749b4cc060
record_format Article
spelling doaj-54c2494225fb490fbda6e1749b4cc0602020-11-25T00:10:48ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-04-011310.3389/fnins.2019.00276412568Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PDLaura de Boni0Ullrich Wüllner1Dementia Research Institute, University College London, London, United KingdomDepartment of Neurology, University Hospital Bonn, German Center for Neurologic Diseases, Bonn, GermanyParkinson’s disease (PD) is the second most common neurodegenerative disorder next to Alzheimer’s disease. Most PD cases are considered to be sporadic and despite considerable scientific effort, the underlying cause(s) still remain(s) enigmatic. In particular, it is unknown to which extent epigenetic alterations contribute to the pathophysiology of this devastating disorder. This is partly due to the fact that appropriate PD models are not yet available. Moreover, epigenetic patterns and mechanisms are species specific and murine systems reflect only a few of the idiosyncrasies of human neurons. For several years now, patient-specific stem cell-derived neural and non-neural cells have been employed to overcome this limitation allowing the analysis and establishment of humanized disease models for PD. Thus, several studies tried to dissect epigenetic alterations such as aberrant DNA methylation or microRNA patterns using lund human mesencephalic cell lines or neurons derived from (patient-specific) induced pluripotent stem cells. These studies demonstrate that human neurons have the potential to be used as model systems for the study of epigenetic modifications in PD such as characterizing epigenetic changes, correlating epigenetic changes to gene expression alterations and hopefully using these insights for the development of novel therapeutics. However, more research is required to define the epigenetic (age-associated) landscape of human in vitro neurons and compare these to native neurons before they can be established as suitable models for epigenetic studies in PD. In this review, we summarize the knowledge about epigenetic studies performed on human neuronal PD models, and we discuss advantages and current limitations of these (stem cell-derived) neuronal models for the study of epigenetic alterations in PD.https://www.frontiersin.org/article/10.3389/fnins.2019.00276/fullstem cellsiPSCneuronshumanepigeneticsParkinson’s disease
collection DOAJ
language English
format Article
sources DOAJ
author Laura de Boni
Ullrich Wüllner
spellingShingle Laura de Boni
Ullrich Wüllner
Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
Frontiers in Neuroscience
stem cells
iPSC
neurons
human
epigenetics
Parkinson’s disease
author_facet Laura de Boni
Ullrich Wüllner
author_sort Laura de Boni
title Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
title_short Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
title_full Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
title_fullStr Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
title_full_unstemmed Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD
title_sort epigenetic analysis in human neurons: considerations for disease modeling in pd
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2019-04-01
description Parkinson’s disease (PD) is the second most common neurodegenerative disorder next to Alzheimer’s disease. Most PD cases are considered to be sporadic and despite considerable scientific effort, the underlying cause(s) still remain(s) enigmatic. In particular, it is unknown to which extent epigenetic alterations contribute to the pathophysiology of this devastating disorder. This is partly due to the fact that appropriate PD models are not yet available. Moreover, epigenetic patterns and mechanisms are species specific and murine systems reflect only a few of the idiosyncrasies of human neurons. For several years now, patient-specific stem cell-derived neural and non-neural cells have been employed to overcome this limitation allowing the analysis and establishment of humanized disease models for PD. Thus, several studies tried to dissect epigenetic alterations such as aberrant DNA methylation or microRNA patterns using lund human mesencephalic cell lines or neurons derived from (patient-specific) induced pluripotent stem cells. These studies demonstrate that human neurons have the potential to be used as model systems for the study of epigenetic modifications in PD such as characterizing epigenetic changes, correlating epigenetic changes to gene expression alterations and hopefully using these insights for the development of novel therapeutics. However, more research is required to define the epigenetic (age-associated) landscape of human in vitro neurons and compare these to native neurons before they can be established as suitable models for epigenetic studies in PD. In this review, we summarize the knowledge about epigenetic studies performed on human neuronal PD models, and we discuss advantages and current limitations of these (stem cell-derived) neuronal models for the study of epigenetic alterations in PD.
topic stem cells
iPSC
neurons
human
epigenetics
Parkinson’s disease
url https://www.frontiersin.org/article/10.3389/fnins.2019.00276/full
work_keys_str_mv AT lauradeboni epigeneticanalysisinhumanneuronsconsiderationsfordiseasemodelinginpd
AT ullrichwullner epigeneticanalysisinhumanneuronsconsiderationsfordiseasemodelinginpd
_version_ 1725407028769193984